Herbert Conrad

Mr. Herbert J.
Conrad is an Independent Director at Celldex Therapeutics, Inc. He is on the Board of Directors at Celldex Therapeutics, Inc. Mr. Conrad was previously employed as an Independent Director by Matinas BioPharma Holdings, Inc., a Chairman by Matinas BioPharma, Inc., a Chairman by Pharmasset, Inc., a Chairman by Sapphire Therapeutics, Inc., a Chairman by GenVec, Inc., a President-US Pharmaceuticals Division by F.
Hoffmann-La Roche Ltd., a President & Director by Roche Pharmaceuticals, Inc., an Independent Director by Arbutus Biopharma Corp., and a Chairman by Bone Care International, Inc. He also served on the board at AVANT Immunotherapeutics, Inc., Symphony Evolution, Inc., Celldex Research Corp., Savient Pharmaceuticals, Inc., Dura Pharmaceuticals, Inc., Gensia Sicor Pharmaceuticals, Inc., Reliant Pharmaceuticals LLC, SICOR, Inc. and UroCor, Inc. He received his undergraduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science and a graduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science.